No Data
No Data
Express News | Zhende Medical: The company does not sell medical products such as masks in the US
Zhende Healthcare (603301): The revenue side can be expected to improve the quarter-on-quarter, and the regular business will accelerate growth
Results were under pressure in 2023 due to reduced demand for quarantine protective equipment and asset impairment. In 2023, the company achieved revenue of 4.127 billion yuan (-32.76%) and net profit to mother of 198 million yuan (-70.87%)
Investors Still Waiting For A Pull Back In Zhende Medical Co., Ltd. (SHSE:603301)
With a price-to-earnings (or "P/E") ratio of 43.5x Zhende Medical Co., Ltd. (SHSE:603301) may be sending bearish signals at the moment, given that almost half of all companies in China have P/E ratios
Zhende Medical (603301.SH) announced first-quarter results, net profit of 73.3976 million yuan, a year-on-year decrease of 49.89%
Zhende Medical (603301.SH) released its report for the first quarter of 2024. The company's revenue was 964 million yuan...
Zhende Medical (603301.SH): The ban on 39.2465 million restricted shares was lifted on March 26
Gelonghui March 20 丨 Zhende Medical (603301.SH) announced that the total number of shares in circulation in the company's current stock listing was 39.2465 million shares. The stock listing and circulation date is March 26, 2024.
Investors Could Be Concerned With Zhende Medical's (SHSE:603301) Returns On Capital
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? Amongst other things, we'll want to see two things; firstly, a growing return on
No Data